ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

0J7G Hutchison China Meditech Ltd

33.29
0.00 (0.00%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Hutchison China Meditech Ltd 0J7G 런던 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 33.29 09:00:00
개장가 저가 고가 종가 전일 종가
33.29 33.29
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
11/01/202416:00RNSNONHutchmed (China) Limited Sovleplenib NDA Granted Priority..
29/12/202317:30UKREGHutchmed (China) Limited Total Voting Rights
29/12/202317:30UKREGHutchmed (China) Limited Blocklisting Six Monthly Return
21/12/202319:00UKREGHutchmed (China) Limited Overseas Regulatory Announcement
13/12/202316:00RNSNONHutchmed (China) Limited Inclusion in National Reimbursement..
07/12/202319:04UKREGHutchmed (China) Limited Overseas Regulatory Announcement
01/12/202316:00RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
30/11/202317:30UKREGHutchmed (China) Limited Total Voting Rights
09/11/202316:00UKREGHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM)..
24/10/202317:30UKREGHutchmed (China) Limited Vesting of awards under the LTIP
16/10/202317:30RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
29/09/202317:30RNSNONHutchmed (China) Limited NDA Submission for Fruquintinib in..
29/09/202317:30UKREGHutchmed (China) Limited Total Voting Rights
14/09/202317:30UKREGHutchmed (China) Limited Director's Share Dealing
12/09/202317:30RNSNONHutchmed (China) Limited Phase IIIb Savolitinib Results at..
12/09/202315:00RNSNONHutchmed (China) Limited Patient Enrollment Completed for..
31/08/202317:30UKREGHutchmed (China) Limited Total Voting Rights
29/08/202315:00RNSNONHutchmed (China) Limited BTD in China for Savolitinib for..
21/08/202315:00UKREGHutchmed (China) Limited Sovleplenib Phase 3 Study Meets..
07/08/202317:30UKREGHutchmed (China) Limited Exercise of Share Options by a..
31/07/202320:00UKREGHutchmed (China) Limited Interim Results and Business..
20/07/202315:00RNSNONHutchmed (China) Limited Breakthrough Therapy Designation..
13/07/202317:30UKREGHutchmed (China) Limited Changes to Board and Technical..
10/07/202315:00RNSNONHutchmed (China) Limited Phase 1 Study of HMPL-415 Initiated
29/06/202317:30UKREGHutchmed (China) Limited Blocklisting Six Monthly Return
26/06/202317:30UKREGHutchmed (China) Limited HUTCHMED to Announce 2023 Half-Year..
16/06/202315:00UKREGHutchmed (China) Limited Phase III FRESCO-2 Results in The..
15/06/202323:39UKREGHutchmed (China) Limited MAA of Fruquintinib Validated by..
09/06/202318:30RNSNONHutchmed (China) Limited HUTCHMED Highlights Presentations..
06/06/202318:00UKREGHutchmed (China) Limited LTIP and Share Option Scheme
31/05/202317:30UKREGHutchmed (China) Limited Total Voting Rights
26/05/202315:00RNSNONHutchmed (China) Limited HUTCHMED Highlights Presentations..
26/05/202315:00UKREGHutchmed (China) Limited Fruquintinib NDA Granted Priority..
17/05/202317:30UKREGHutchmed (China) Limited Standard form for notification of..
12/05/202321:15UKREGHutchmed (China) Limited Annual General Meeting Poll Results
12/05/202317:30UKREGHutchmed (China) Limited Board of Directors and Board..
10/05/202317:30UKREGHutchmed (China) Limited Appointment of Independent NED

최근 히스토리

Delayed Upgrade Clock